Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1880

1.

Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.

Hayashi PH, Forman L, Steinberg T, Bak T, Wachs M, Kugelmas M, Everson GT, Kam I, Trotter JF.

Liver Transpl. 2003 Jul;9(7):737-40.

2.

Live donor liver transplantation in high MELD score recipients.

Selzner M, Kashfi A, Cattral MS, Selzner N, McGilvray ID, Greig PD, Levy GA, Renner EL, Grant DR.

Ann Surg. 2010 Jan;251(1):153-7. doi: 10.1097/SLA.0b013e3181bc9c6a.

PMID:
19858705
3.

Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.

Yi NJ, Suh KS, Lee HW, Shin WY, Kim J, Kim W, Kim YJ, Yoon JH, Lee HS, Lee KU.

Liver Transpl. 2009 May;15(5):496-503. doi: 10.1002/lt.21606.

4.

Use of the Model for End-Stage Liver Disease (MELD) score to predict 1-year survival of Japanese patients with cirrhosis and to determine who will benefit from living donor liver transplantation.

Ishigami M, Honda T, Okumura A, Ishikawa T, Kobayashi M, Katano Y, Fujimoto Y, Kiuchi T, Goto H.

J Gastroenterol. 2008;43(5):363-8. doi: 10.1007/s00535-008-2168-7. Epub 2008 Jul 1.

PMID:
18592154
5.

[Influence of recipient pretransplant MELD-AS score and graft size on the outcome of adult-to-adult living donor liver transplantation].

Feng X, Wei YG, Li FQ, Yuan D, Jiang H, Du ZG, Yin J, Li B.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2008 Sep;39(5):801-4. Chinese.

PMID:
19024318
6.

Impact of pretransplant MELD score on posttransplant outcome in living donor liver transplantation.

Akyildiz M, Karasu Z, Arikan C, Kilic M, Zeytunlu M, Gunsar F, Ersoz G, Akarca U, Batur Y, Tokat Y.

Transplant Proc. 2004 Jun;36(5):1442-4.

PMID:
15251354
7.

The model for end-stage liver disease score is useful for predicting economic outcomes in adult cases of living donor liver transplantation.

Kogure T, Ueno Y, Kawagishi N, Kanno N, Yamagiwa Y, Fukushima K, Satomi S, Shimosegawa T.

J Gastroenterol. 2006 Oct;41(10):1005-10. Epub 2006 Nov 9.

PMID:
17096070
8.

A graft to body weight ratio less than 0.8 does not exclude adult-to-adult right-lobe living donor liver transplantation.

Selzner M, Kashfi A, Cattral MS, Selzner N, Greig PD, Lilly L, McGilvray ID, Therapondos G, Adcock LE, Ghanekar A, Levy GA, Renner EL, Grant DR.

Liver Transpl. 2009 Dec;15(12):1776-82. doi: 10.1002/lt.21955.

9.

Donor and recipient selection leads to good patient and graft outcomes for right lobe split transplantation versus whole graft liver transplantation in adult recipients.

Sandroussi C, Crawford M, Lockwood DS, Tang P, Gallagher JP, Pleass H, Strasser SI, Shackel NA, McCaughan GW, Verran DJ.

Liver Transpl. 2009 Nov;15(11):1586-93. doi: 10.1002/lt.21849.

10.

MELD and prediction of post-liver transplantation survival.

Habib S, Berk B, Chang CC, Demetris AJ, Fontes P, Dvorchik I, Eghtesad B, Marcos A, Shakil AO.

Liver Transpl. 2006 Mar;12(3):440-7.

11.

Emergent right lobe adult-to-adult living-donor liver transplantation for high model for end-stage liver disease score severe hepatitis.

Shi-Chun L, Meng-Long W, Ning L, Wei L, Ping C, Jin-Ning L, Jun D, Zhen Z, Ju-Shan W, Dong-Dong L, Qing-Liang G, Yue Z.

Transpl Int. 2010 Jan;23(1):23-30.

PMID:
20050081
12.

MELD score versus conventional UNOS status in predicting short-term mortality after liver transplantation.

Santori G, Andorno E, Morelli N, Antonucci A, Bottino G, Mondello R, Castiglione AG, Valente R, Ravazzoni F, Di Domenico S, Valente U.

Transpl Int. 2005 Jan;18(1):65-72.

13.

Right-liver living donor transplantation for decompensated end-stage liver disease.

Testa G, Malagó M, Nadalin S, Hertl M, Lang H, Frilling A, Broelsch CE.

Liver Transpl. 2002 Apr;8(4):340-6.

16.

Performance of posttransplant Model for End-Stage Liver Disease (MELD) and delta-MELD scores on short-term outcome after living donor liver transplantation.

Kim JD, Choi JY, Kwon JH, Jang JW, Bae SH, Yoon SK, You YK, Kim DG.

Transplant Proc. 2009 Nov;41(9):3766-8. doi: 10.1016/j.transproceed.2009.10.006.

PMID:
19917383
17.

Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list.

Ferraz-Neto BH, Hidalgo R, Thomé T, Melo VA Jr, Lobue A, Zurstrassen MP, Moraes JM Jr, Meira-Filho SP, Rezende MB, Fonseca LE, Pandullo FL, Soeiro FS, Afonso RC.

Transplant Proc. 2007 Oct;39(8):2511-3.

PMID:
17954160
18.

Living donor liver transplantation for hepatitis C-related cirrhosis: no difference in histological recurrence when compared to deceased donor liver transplantation recipients.

Guo L, Orrego M, Rodriguez-Luna H, Balan V, Byrne T, Chopra K, Douglas DD, Harrison E, Moss A, Reddy KS, Williams JW, Rakela J, Mulligan D, Vargas HE.

Liver Transpl. 2006 Apr;12(4):560-5.

19.

Impact of MELD on short-term and long-term outcome following liver transplantation: a European perspective.

Nagler E, Van Vlierberghe H, Colle I, Troisi R, de Hemptinne B.

Eur J Gastroenterol Hepatol. 2005 Aug;17(8):849-56.

PMID:
16003135
20.

Pretransplant Model for End-stage Liver Disease score has no impact on posttransplant survival in living donor liver transplantation.

Wai CT, Woon WA, Tan YM, Lee KH, Tan KC.

Transplant Proc. 2012 Mar;44(2):396-8. doi: 10.1016/j.transproceed.2012.01.030.

PMID:
22410026

Supplemental Content

Support Center